These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16436886)

  • 41. Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device.
    Loebe M; Koster A; Sänger S; Potapov EV; Kuppe H; Noon GP; Hetzer R
    ASAIO J; 2001; 47(3):272-4. PubMed ID: 11374772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal function and outcome after continuous flow left ventricular assist device implantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Grimm M; Wolner E; Wieselthaler GM
    Ann Thorac Surg; 2009 Apr; 87(4):1072-8. PubMed ID: 19324130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracorporeal membrane oxygenation hybrid with various ventricular assist devices as double bridge to heart transplantation.
    Chou NK; Chen YS; Chi NH; Hsu RB; Ko WJ; Yu HY; Lin FY; Wang SS
    Transplant Proc; 2006 Sep; 38(7):2127-9. PubMed ID: 16980020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry.
    Patlolla V; Patten RD; Denofrio D; Konstam MA; Krishnamani R
    J Am Coll Cardiol; 2009 Jan; 53(3):264-71. PubMed ID: 19147043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Papworth experience with the Levitronix CentriMag ventricular assist device.
    Shuhaiber JH; Jenkins D; Berman M; Parameshwar J; Dhital K; Tsui S; Large SR
    J Heart Lung Transplant; 2008 Feb; 27(2):158-64. PubMed ID: 18267221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulsatile left ventricular assist devices: what is the role in the modern era?
    Atluri P; Acker MA
    Semin Thorac Cardiovasc Surg; 2010; 22(2):106-8. PubMed ID: 21092883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devices.
    Schulman AR; Martens TP; Christos PJ; Russo MJ; Comas GM; Cheema FH; Naseem TM; Wang R; Idrissi KA; Bailey SH; Naka Y
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):841-2. PubMed ID: 17320612
    [No Abstract]   [Full Text] [Related]  

  • 48. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
    Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
    Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful replacement of malfunctioning TCI HeartMate LVAD with DeBakey LVAD as a bridge to heart transplantation.
    Russo CF; Fratto PA; Milazzo F; Vitali E
    Interact Cardiovasc Thorac Surg; 2004 Dec; 3(4):542-3. PubMed ID: 17670305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human leukocyte antigen sensitization in ventricular assist device recipients: a lesser risk with the DeBakey axial pump.
    Grinda JM; Bricourt MO; Amrein C; Salvi S; Guillemain R; Francois A; Guibourt P; Deloche A; Fabiani JN
    Ann Thorac Surg; 2005 Sep; 80(3):945-8. PubMed ID: 16122460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of device surface and biomaterials with immunologic sensitization after mechanical support.
    George I; Colley P; Russo MJ; Martens TP; Burke E; Oz MC; Deng MC; Mancini DM; Naka Y
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1372-9. PubMed ID: 18544389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulsatile ECMO and VAD: a dual use of a new device in pediatric cardiac patients.
    Agati S; Ciccarello G; Ocello S; Salvo D; Marcelletti C; Undar A; Mignosa C
    ASAIO J; 2006; 52(5):501-4. PubMed ID: 16966845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device.
    Baran DA; Gass AL; Galin ID; Zucker MJ; Arroyo LH; Goldstein DJ; Prendergast T; Lubitz S; Courtney MC; Correa R; Chan M; Spielvogel D; Lansman SL
    J Heart Lung Transplant; 2005 Nov; 24(11):1886-90. PubMed ID: 16297796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive brain function after hypothermic circulatory arrest assessed by cognitive P300 evoked potentials.
    Kunihara T; Tscholl D; Langer F; Heinz G; Sata F; Schäfers HJ
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):507-13. PubMed ID: 17627831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Ventricular assist devices as bridge to heart transplantation in cardiogenic shock or terminal heart failure--12 years experience at the Sheba Medical Center].
    Lavee J; Kassif Y; Freimark D; Har Zahav Y; Koman V; Preisman S; Smolinsky A; Raanani E
    Harefuah; 2007 Nov; 146(11):833-6, 911. PubMed ID: 18087826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Malehsa D; Meyer AL; Bara C; Strüber M
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1091-3. PubMed ID: 19303790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opening the cardiac chambers does not make any difference in p300 measurement.
    Iskesen I; Yilmaz H; Yildirim F; Selcuki D
    Heart Surg Forum; 2006; 9(5):E770-3. PubMed ID: 16844636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical significance of PlA polymorphism of platelet GP IIb/IIIa receptors during long-term VAD support.
    Potapov EV; Ignatenko S; Nasseri BA; Loebe M; Harke C; Bettmann M; Doller A; Regitz-Zagrosek V; Hetzer R
    Ann Thorac Surg; 2004 Mar; 77(3):869-74; discussion 874. PubMed ID: 14992889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
    Greenberg B; Czerska B; Delgado RM; Bourge R; Zile MR; Silver M; Klapholz M; Haeusslein E; Mehra MR; Mather P; Abraham WT; Neaton JD; Brown BS; Parker IC; Konstam MA;
    Circulation; 2008 Sep; 118(12):1241-9. PubMed ID: 18765394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.